Benzoxaborole antibiotic

This page covers all Benzoxaborole antibiotic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Leucyl-tRNA synthetase (LeuRS).

Targets

Leucyl-tRNA synthetase (LeuRS)

Phase 3 pipeline (1)

• BV100 (300 mg) · BioVersys SAS · Infectious Disease
  BV100 is a benzoxaborole antibiotic that inhibits bacterial leucyl-tRNA synthetase, disrupting protein synthesis in susceptible pathogens.

Patent intelligence

• benzoxaborole antibiotic patent landscape — aggregated cliff calendar, attackable patents, originator estates